Annual Cash & Cash Equivalents
$99.59 M
-$3.23 M-3.14%
December 31, 2024
Summary
- As of March 12, 2025, VRDN annual cash & cash equivalents is $99.59 million, with the most recent change of -$3.23 million (-3.14%) on December 31, 2024.
- During the last 3 years, VRDN annual cash & cash equivalents has risen by +$57.30 million (+135.45%).
- VRDN annual cash & cash equivalents is now -35.98% below its all-time high of $155.58 million, reached on December 31, 2022.
Performance
VRDN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$99.59 M
-$100.72 M-50.28%
December 1, 2024
Summary
- As of March 12, 2025, VRDN quarterly cash and cash equivalents is $99.59 million, with the most recent change of -$100.72 million (-50.28%) on December 1, 2024.
- Over the past year, VRDN quarterly cash and cash equivalents has dropped by -$3.23 million (-3.14%).
- VRDN quarterly cash and cash equivalents is now -71.07% below its all-time high of $344.21 million, reached on September 30, 2022.
Performance
VRDN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRDN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.1% | -3.1% |
| 3 y3 years | +135.4% | -10.8% |
| 5 y5 years | +300.9% | -10.8% |
VRDN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.0% | +135.4% | -71.1% | +222.8% |
| 5 y | 5-year | -36.0% | +300.9% | -71.1% | +300.9% |
| alltime | all time | -36.0% | >+9999.0% | -71.1% | >+9999.0% |
Viridian Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $99.59 M(-3.1%) | - |
| Dec 2024 | - | $99.59 M(-50.3%) |
| Sep 2024 | - | $200.32 M(+86.1%) |
| Jun 2024 | - | $107.67 M(+17.5%) |
| Mar 2024 | - | $91.64 M(-10.9%) |
| Dec 2023 | $102.83 M(-33.9%) | $102.83 M(-7.9%) |
| Sep 2023 | - | $111.60 M(+28.2%) |
| Jun 2023 | - | $87.08 M(-1.6%) |
| Mar 2023 | - | $88.52 M(-43.1%) |
| Dec 2022 | $155.58 M(+267.8%) | $155.58 M(-54.8%) |
| Sep 2022 | - | $344.21 M(+1000.0%) |
| Jun 2022 | - | $31.29 M(+1.4%) |
| Mar 2022 | - | $30.86 M(-27.0%) |
| Dec 2021 | $42.30 M(-7.8%) | $42.30 M(-69.5%) |
| Sep 2021 | - | $138.88 M(+401.3%) |
| Jun 2021 | - | $27.70 M(-40.4%) |
| Mar 2021 | - | $46.49 M(+1.3%) |
| Dec 2020 | $45.90 M(+84.7%) | $45.90 M(+52.6%) |
| Sep 2020 | - | $30.08 M(-1.6%) |
| Jun 2020 | - | $30.58 M(-15.3%) |
| Mar 2020 | - | $36.10 M(+45.3%) |
| Dec 2019 | $24.85 M | $24.85 M(-0.0%) |
| Sep 2019 | - | $24.86 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $24.01 M(+31.9%) |
| Mar 2019 | - | $18.20 M(-44.2%) |
| Dec 2018 | $32.61 M(-31.3%) | $32.61 M(+2.9%) |
| Sep 2018 | - | $31.70 M(-27.0%) |
| Jun 2018 | - | $43.40 M(-44.4%) |
| Mar 2018 | - | $78.10 M(+64.6%) |
| Dec 2017 | $47.44 M(+1320.0%) | $47.44 M(+10.8%) |
| Sep 2017 | - | $42.80 M(-7.6%) |
| Jun 2017 | - | $46.34 M(-14.6%) |
| Mar 2017 | - | $54.27 M(+1524.5%) |
| Dec 2016 | $3.34 M(-69.2%) | $3.34 M(-37.6%) |
| Sep 2016 | - | $5.35 M(-17.7%) |
| Jun 2016 | - | $6.50 M(-24.1%) |
| Mar 2016 | - | $8.56 M(-21.0%) |
| Dec 2015 | $10.83 M(+111.6%) | $10.83 M(-10.7%) |
| Sep 2015 | - | $12.12 M(+16.0%) |
| Jun 2015 | - | $10.45 M(-21.3%) |
| Mar 2015 | - | $13.27 M(+159.2%) |
| Dec 2014 | $5.12 M(+2349.3%) | $5.12 M(-19.9%) |
| Sep 2014 | - | $6.39 M(-17.0%) |
| Jun 2014 | - | $7.70 M(+7222.8%) |
| Mar 2014 | - | $105.10 K(-49.7%) |
| Dec 2013 | $209.00 K(+85.8%) | $209.00 K |
| Dec 2012 | $112.50 K | - |
FAQ
- What is Viridian Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Viridian Therapeutics?
- What is Viridian Therapeutics annual cash & cash equivalents year-on-year change?
- What is Viridian Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Viridian Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VRDN is $99.59 M
What is the all time high annual cash & cash equivalents for Viridian Therapeutics?
Viridian Therapeutics all-time high annual cash & cash equivalents is $155.58 M
What is Viridian Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VRDN annual cash & cash equivalents has changed by -$3.23 M (-3.14%)
What is Viridian Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VRDN is $99.59 M
What is the all time high quarterly cash and cash equivalents for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly cash and cash equivalents is $344.21 M
What is Viridian Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, VRDN quarterly cash and cash equivalents has changed by -$3.23 M (-3.14%)